Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolargo Inc (OP: BLGO )

0.1876 UNCHANGED
Streaming Delayed Price Updated: 3:53 PM EST, Dec 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1876
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1876
Today's Range 0.1876 - 0.1876
52wk Range 0.1604 - 0.4499
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioLargo's Year-to-Date Revenues Up 80%
Via ACCESSWIRE
BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time
Via ACCESSWIRE

Performance

YTD
+12.34%
+12.34%
1 Month
-11.51%
-11.51%
3 Month
-24.35%
-24.35%
6 Month
-31.78%
-31.78%
1 Year
+16.96%
+16.96%

More News

Read More
BioLargo, Inc. to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
CleanTech Innovator Delivers Long-Range, Safe Battery Tech
Via News Direct
BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
Via ACCESSWIRE
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
From Gabelli Funds
Via GlobeNewswire
BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
Via ACCESSWIRE
BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
Via ACCESSWIRE
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
From Gabelli Funds
Via GlobeNewswire
Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer
Via ACCESSWIRE
BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time
Via ACCESSWIRE
BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
Via ACCESSWIRE
EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
Via ACCESSWIRE
BioLargo PFAS Removal Technology Meets New US Drinking Water Standards
Via ACCESSWIRE
BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
Via ACCESSWIRE
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
Via ACCESSWIRE
BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project
Via ACCESSWIRE
BioLargo Generates Positive Operating Cash Flow on Record Quarterly Revenues for First Quarter of 2024
Via ACCESSWIRE
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
From OTC Markets
Via GlobeNewswire
BioLargo Q1 2024 Earnings Results Webcast and Conference Call on Tuesday, May 14, 2024 - 5:30 PM Eastern Time
Via ACCESSWIRE
BioLargo, Inc. (BLGO) Leads in Cleantech Innovation with AEC Technology
Via Investor Brand Network
AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11
From Virtual Investor Conferences
Via GlobeNewswire
BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023
Via ACCESSWIRE
Gabelli Funds to Host 10th Annual Waste & Environmental Services Symposium Thursday, April 4, 2024
From Gabelli Funds
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.